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Abstract. During metanephric development, non-polar- 
ized mesenchymal cells are induced to form the epi- 
thelial structures of the nephron following interaction 
with extracellular matrix proteins and factors produced 
by the inducing tissue, ureteric bud. This induction 
can occur in a transfilter organ culture system where it 
can also be produced by heterologous cells such as the 
embryonic spinal cord. We found that when embryonic 
mesenchyme was induced in vitro and in vivo, many 
of the cells surrounding the new epithelium showed 
morphological evidence of programmed cell death 
(apoptosis) such as condensed nuclei,  fragmented cy- 
toplasm, and cell shrinking.  A biochemical correlate 
of apoptosis is the transcriptional  activation of a cal- 
cium-sensitive endonuclease. Indeed,  DNA isolated 
from uninduced mesenchyme showed progressive degra- 
dation, a process that was prevented by treatment with 
actinomycin-D or cycloheximide and by buffering intra- 
cellular calcium.  These results demonstrate that the 
metanephric mesenchyme is programmed for apoptosis. 
Incubation of mesenchyme with a heterologous in- 
ducer, embryonic spinal cord prevented this DNA deg- 
radation.  To investigate the mechanism by which in- 
ducers prevented apoptosis we tested the effects of 
protein kinase C modulators on this process. Phorbol 
esters mimicked the effects of the inducer and stauro- 
sporine,  an inhibitor of this protein kinase, prevented 
the effect of the inducer.  EGF also prevented DNA 
degradation but did not lead to differentiation.  These 
results demonstrate that conversion of mesenchyme to 
epithelia requires at least two steps, rescue of the 
mesenchyme from apoptosis and induction of differ- 
entiation. 
C 
ONVERSION of mesenchyme to epithelia  during  kid- 
ney organogenesis  occurs when the ureteric bud in- 
duces the mesenchyme to differentiate, a process that 
can be recapitulated  in vitro using a transfilter organ culture 
system (7, 21). Invasion of the mesenchyme by the ureteric 
bud causes the appearance of epithelial cell markers such as 
type IV collagen, the alpha chain of laminin and uvomorulin, 
and the disappearance of mesenchymal  proteins such as vi- 
mentin  and N-CAM (4).  Immediately following  induction 
the cells undergo a burst of proliferation  which raised the 
question of whether all the cells in the metanephric  mesen- 
chyme contributed to the formation  of mature nephrons  or 
whether only some of the cells were selected for differentia- 
tion.  During morphogenesis of some tissues,  ceils are pro- 
duced in large excess but rapidly die and only a few remain 
to form the mature tissue (5, 27). 
Cell death occurs by two processes, necrosis or apoptosis 
whose cytological and biochemical characteristics  are dis- 
tinct (1, 5, 18, 25, 27). At the morphological level, necrosis 
is associated with early cell swelling and lysis of intracellular 
organelles  but nuclear breakdown is a late event.  On the 
other hand, in apoptosis (also termed programmed cell death 
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or cell suicide),  nuclear fragmentation  is observed early in 
the course and is associated with cytoplasmic shrinking and 
preservation  of intracellular  organelles.  The cells eventually 
become fragmented  and are phagocytosed by neighboring 
cells or by macrophages.  In necrosis which is frequently as- 
sociated with cell injury, the ATP levels fall early and protein 
synthesis is consequently inhibited.  In apoptosis, ATP levels 
are  frequently  normal  and  protein  synthesis  is  often in- 
creased. In fact, apoptosis can be prevented by inhibitors  of 
RNA and protein synthesis.  A characteristic  finding is the 
early degradation of DNA to a size of 180-200 bp suggesting 
the activation  of an endonuclease that  digests  DNA at the 
nucleosomes (26).  This  endonuclease is calcium activated 
(27). 
Apoptosis plays an important role in morphogenesis  of a 
variety of systems (5). It is responsible for clonal deletion in 
thymic development and maturation  (15). Apoptosis allows 
the formation of digits when the interdigital  cells die. In neu- 
ral development  it determines the correct relation  between 
the size of sensory neural area and that of its target. In worm 
and  insect  development,  several  genes  have  been  found 
whose disruption prevents apoptosis, one of which appears 
to contain a calcium-binding  motif (5). The study of apopto- 
sis has emphasized its role in the development of specific or- 
gans or tissues,  but recent evidence has suggested  a more 
generalized  role  (18). A  gene  was  recently  identified  in 
Caenorhabditis elegans, ced-9 whose expression was fotrnd 
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many cell types can constitutively progress towards apopto- 
sis but need a factor that will rescue them from this fate (8). 
While performing  studies  on the  lineage of cells during 
metanephric development (9),  we noticed that the cells sur- 
rounding the induced mesenchyme showed the morphologi- 
cal  and  biochemical  characteristics  of  programmed  cell 
death. An examination of the mechanism by which apoptosis 
was prevented in the selected cells suggests that activation of 
protein kinase C and possibly tyrosine kinases by the inducer 
is required  for this  inhibition of apoptosis. 
Materials and Methods 
The transfilter culture of mesencbyme  was performed  as previously  de- 
scribed (1 I). Embryonic kidney and spinal cord were microdissected from 
gestation day 13 rat embryos at which time the ureteric bud had just started 
to penetrate the mesenchyme. Metanephric mesenchyme was freed from the 
endogenous inducer (ureteric bud) and placed on a transftlter (Transwoll, 
pore size 3 #m; Costar, Cambridge, UK) and cultured for 24 h in the pres- 
ence or absence of heterologous inducer. The embryonic dorsal spinal cord 
was attached to the under surface of the filter. For microscopy, the tissue 
was fixed with 2% paraformaldehyde in phosphate buffered saline and em- 
bedded in HistoResin (Kulzer, Heidelberg, Germany). 4-#m sections were 
stained with hematoxylin and eosin. 
Measurement of  DNA Degradation 
The mesenchyme was microdissected from El3 embryos, isolated from ure- 
teric  bud  and  incubated  with  25 #Ci [3H]thymidine (Amersham  Corp., 
Arlington Heights, IL) in DME containing 10% FCS for 2 h at 37~  The 
explants were then transferred onto the transfilter system and incubated in 
the absence of isotope for an additional 4-6 h in the presence or absence 
of  added reagents. Before DNA extraction, the kidney mesenchyme was first 
dissociated by 5% trypsin in PBS for 30 rain at 37~  DNA was extracted 
as described (16) except that proteinase K treatment and phenol extraction 
were repeated twice.  Extracted  DNA was suspended in 15 #1 tris-EDTA 
buffer and separated in 0.6% agarose gel containing ethidium bromide. The 
agarose gel was cut into 12 4-ram slices. Each slice was extracted in scintil- 
lation medium (Ready protein,  Beckman Instruments,  Palo Alto, CA) and 
radioactivity was measured. High molecular weight DNA is defined as the 
top three fractions of the ngarose gel encompassing DNA fragments >5 kb 
and is expressed as a fraction of the total counts in the gel. 
All assays were performed in a paired manner where each assay point 
used kidneys from three embryos. Each point was repeated three to seven 
times as noted in the text. In the experiments where the effects  of  the inducer 
was tested, only the dorsal spinal cord was used as an inducer since it was 
difficult to obtain enough quantities of the ureteric bud.  In some experi- 
ments the dorsal embryonic spinal cord was cut into small pieces and in- 
cubated around the rudiments while in others a homogenate of the spinal 
cord was used. Spinal cord was homogenized by ten strokes in a glass/glass 
homogenizer in  10%  FCS in DME. Examination of the homogenate re- 
vealed that it contained isolated viable cells as well as cell fragments. After 
the appropriate  incubation period,  the mesenchyme was frozen at  -70~ 
until the DNA was extracted. 
The final concentration  of the various  added  reagents  was,  5  #g/ml 
actinomycin-D (Sigma Chemical Co., St. Louis,  MO);  10 #M cyclohexi- 
mide (Sigma Chemical Co.); 20 #M BAPTA-AM (Molecular Probes Inc., 
Eugene, OR); 20 #M PMA (Sigma Chemical Co.); and 0.1 #M staurosporin 
(Calbiochem-Behring Corp., San Diego, CA). 
Since each set of experiments was performed as a pair where fragments 
of metanephric mesenchyme were taken from the same animals and divided 
into two (or more) parts to examine the effect of additives, statistics were 
performed using the paired t-test where n refers to the number of experi- 
ments performed. 
Results 
When metanephric mesenchyme was isolated at embryonic 
day  13  (El3)  from rat embryos  and  studied  in a  transfilter 
assay,  the uninduced  mesenchyme  showed all the morpho- 
logical characteristics  of apoptosis  including  cell and  nu- 
clear fragmentation and condensed nuclei, (Fig.  1 A). While 
the induced mesenchyme converted to an epithelium (Fig.  1 
B),  it remained surrounded  by cells that  showed apoptotic 
changes. The experiment of Fig. 1 was performed 4-6 h after 
setting up the assay, hence the morphology does not show ad- 
vanced tubulogenesis. It takes at least 24-48 h to have recog- 
nizable tubules. 
Figure 1. Transfilter culture of metanephric mesenchyme in the presence (right) and absence (left) of embryonic spinal cord.  Note that 
most nuclei in the left panel are small, dense, and fragmented when compared to the nuclei of the induced sample. Note also that nuclear 
fragmentation is present in cells that surround  the induced mesenchyme in the right panel as well. 
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onic kidneys. Note the groups of apoptotic cells outside the developing tubules. 
Examination of sections  of embryonic kidney  isolated 
from later stages of development (El4 and El9 embryos) 
showed that there were islands of apoptotic cells between de- 
veloping nephrons (Fig. 2). These results demonstrate that 
apoptosis is  a  prominent feature of metanephric develop- 
ment and is not an artifact of the in vitro transfilter assay 
system. 
One of the characteristics of apoptosis is the synthesis of 
a calcium-sensitive endonuclease (26, 27). To test for activa- 
tion of this enzyme in the metanephric mesenchyme we in- 
cubated  El3  mesenchyme in  a  transfilter  chamber  with 
[3H]thymidine for 2 h and isolated DNA at different times of 
culture and analyzed it by agarose gel electrophoresis. DNA 
was degraded rapidly such that by 24 h all of the DNA was 
in low molecular weight form and by 48 h all of the DNA 
was about 200 bp in size (Fig. 3).  High molecular weight 
DNA (>5  kb)  was reduced to 35-45 % of the total DNA 
within 6 h of incubation. When uninduced mesenchyme was 
incubated with the inhibitors of RNA synthesis (actinomycin 
D) or protein synthesis (cycloheximide), the fraction of  DNA 
that was in high molecular weight increased to 74 and 81%, 
respectively (n =  5 each; P < 0.01) (Fig. 4, A and B). The 
endonuclease of apoptosis is known to be activated by diva- 
lent cations. We buffered the intracenular calcium by incu- 
bating the mesenchyme in the permeant calcium chelator, 
BAPTA-AM and found that this also significantly prevented 
the degradation of DNA  (Fig.  4  C).  Inhibition of DNA 
degradation by these reagents did not lead to tubulogenesis 
as assayed morphologically (data not shown). These mor- 
phological  and  biochemical  results  demonstrate  that  the 
metanephric mesenchyme is programmed for apoptosis. 
We also performed experiments to test for DNA degrada- 
tion during kidney development in situ. Kidney rudiments 
were removed from E13-E19  embryos and labeled for 2 h 
with [3H]thymidine.  The DNA was then extracted without 
further incubation and separated on agarose gels. As shown 
in Table I, there was DNA degradation in situ at all stages 
of kidney development which amounted to ~,10 % of the total 
DNA at E12-E14.  At later stages of development, El5 and 
El9 there appeared to be an increase in the level of DNA 
degradation.  That DNA degradation was demonstrated in 
situ, suggests that apoptosis is one of the physiological con- 
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Figure 3.  DNA degradation in mesenchymal cells. Metanephric 
rudiments were isolated from El3 embryos and labeled with [3H]- 
thymidine for 2 h and the DNA was immediately extracted and sep- 
arated on agarose gels (o---o), or incubated for 24 (~----~), or 
48 h  (A  -') at 37~  in the absence of label before extraction. 
DNA is expressed as % of the total cpm. The total amount of 3H 
label present in the 24- and 48-h experiments was less than 25 % of  the 
initial label suggesting that by that time most of the DNA bad been 
degraded to small molecular weight DNA and was lost either dur- 
ing extraction or during electrophoresis. The 21-kb marker is at the 
first or second slice and the 0.2 kb would be in slice 10-12. 
Table L  Fraction  of Total [SH]Thymidine-labeled  DNA in 
High Molecular Form (Perccent HMWDNA) 
DNA Degradaton In Situ 
Gestation  age  El2  El3  El4  El5  El9 
Percent 
HMWDNA  92  +  1  91  +  2  91  5:2  83  5:5  67  5:10 
n  3  5  5  5  4 
Kidneys were removed from gestation day 12 to 19 and incubated in [gH]thy- 
midine for 2 h. DNA was extracted and separated on agarose gels. HMWDNA 
is defined as the top three fractions of the gel comprising DNA greater than 
5 kb in molecular weight. 
comitants  of metanephric  development  and  confirms  the 
morphological findings of Fig. 2. 
Conversion of kidney mesenchyme occurs when an out- 
growth of the Wolflian duct, the ureteric bud, invades it and 
causes the appearance of epithelial markers (4, 21). In early 
experiments,  Grobstein  found  that  the  process  of mesen- 
chymal conversion can occur in vitro in transfilter organ cul- 
tures and that it can also be produced by a heterologous in- 
ducer, embryonic spinal cord (6, 7). We tested the hypothesis 
that the inducer rescues the mesenchyme from apoptosis by 
studying DNA fragmentation. In all our studies we used the 
embryonic spinal cord since the dissection and isolation of 
,< 
z 
a 
i 
9O 
A 
80 
7O 
60 
50 
40 
i 
Ar 
.< 
z 
a 
-r 
o~ 
9O 
B 
80 
70 
GO 
50 
40 
1 
Cychx 
< 
z 
s 
-I- 
60 
C 
50 
40 
30 
C  BAPTA 
Figure 4. DNA degradation in mesenchymal ceils. High molecular weight DNA (HMW DNA) as a fraction of total DNA is plotted for 
different experimental conditions. (A) Actinomycin D, 5 #g/ml; n  =  5.  (B) Cycloheximide, 10 #M, n  =  5; (C) BAPTA-AM, 20 #M, 
n  =  5; P <  0.01 for all additions compared to no additions. 
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Figure 5. DNA degradation in mesenchymal cells cultured with em- 
bryonic spinal cord. (SC), n  =  7, P < 0.01. 
the ureteric bud proved difficult. We found that DNA frag- 
mentation was prevented when mesenchyme was incubated 
with embryonic spinal cord, Fig. 5. The protection afforded 
by spinal cord was much weaker than the effect of inhibitors 
of protein and RNA synthesis. Reducing the amount of in- 
ducer at constant target mesenchyme size reduced the effect 
(data not shown). 
Induction by the spinal cord could occur by either secret- 
ing a factor that activates the mesenchyme or by cell to cell 
contact. Both mechanisms act on the surface and hence there 
must be some kind of signal transduction mechanism to al- 
low the inhibition of apoptosis. PMA, an activator of protein 
kinase C was found to inhibit apoptosis in lymphocytes (17), 
and it also reduced DNA degradation in metanephric mesen- 
chyme (Fig. 6, top). PMA did not result in any additive effect 
when it was used with the spinal cord, Fig. 6 A suggesting 
that the inducer itself acts through this pathway. Stronger evi- 
dence was provided by the finding that staurosporin, an in- 
hibitor of protein kinase C, prevented the protective effect of 
the inducer on DNA degradation (Fig. 6 B). Morphological 
observation of explants which were devoid of ureteric bud 
showed that phorbol esters did not cause the appearance of 
tubules (data not shown). 
Recently, Weller et al. (24) studied the effect of a number 
of  soluble  growth  factors  on  the  conversion  of  mouse 
metanephric mesenchyme and found that none of a  large 
number of factors including EGF were capable of inducing 
the conversion. However, EGF caused an increase in DNA 
synthesis. The metanephric rudiment produces TGF alpha 
(which binds to the EGF receptor) and antibodies to this 
growth factor prevent tubulogenesis in rat metanephros sug- 
gesting that this protein is necessary for renal development 
(20). We studied the effect  of EGF on apoptosis in rat mesen- 
chyme and found that it prevented the degradation of DNA 
that occurs in the absence of  the inducer, Fig. 7. These results 
imply that prevention of apoptosis can be achieved by activa- 
tion of protein kinase C or a tyrosine kinase. Since tyrosine 
kinases  frequently  constitute  the  cytoplasmic  portion  of 
receptors for several growth factors and hormones while 
protein kinase C is usually downstream from plasma mem- 
brane receptors, the present results suggest that such a cas- 
cade might be involved in the inhibition of apoptosis. 
Discussion 
Cell death occurs by two mechanisms, apoptosis and necro- 
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Figure 6. Role of protein kinase C in DNA degradation in mesen- 
chymal cells. In these experiments, embryonic kidneys from each 
animal were divided into four samples for the experiments in Fig. 
6, top, and into three samples for those of  Fig. 6, bottom. Each assay 
point used kidneys from three animals. Each experiment was re- 
peated three times. SC, embryonic spinal cord; P < 0.05 when com- 
pared to no additions, in top and bottom. 20/~M PMA; P < 0.05 
when compared to no addition. 100 nM Staurosporine. 
sis which can be distinguished by morphological and bio- 
chemical methods.  Apoptosis  is  characterized by nuclear 
and cytoplasmic condensation and fragmentation. Its cardi- 
nal biochemical feature is DNA degradation by a mechanism 
that can be blocked by inhibitors of  protein and RNA synthe- 
sis. Where tested, the DNA degradation was found to be cal- 
cium dependent. In necrosis the initial event is cell swelling 
and vacuolation. When nuclear breakdown occurs it is a late 
event and is not associated with condensation of the nucleus. 
Examination of Figs.  1 and 2  shows  that the cells demon- 
strate condensation and fragmentation, findings characteris- 
tic of apoptosis. We have also demonstrated that inhibitors 
of RNA and protein synthesis reduced DNA degradation. If 
the DNA breakdown was produced by an artifact of the in 
vitro system causing cell death (presumably by necrosis) one 
would have expected that potent poisons such as actinomycin 
D and cycloheximide would have increased DNA degrada- 
tion not reduce it. We also provided evidence that apoptosis 
occurs in situ during metanephric development further sup- 
porting our contention that apoptosis is a normal concomi- 
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Figure 7. Effect of epidermal growth factor on DNA degradation 
in mesenchymal cells. Epidermal growth factor (EGF) 40 ng/ml, 
n  =5, P<0.05. 
tant of kidney morphogenesis. That we found that embryonic 
spinal cord, a heterologous inducer of metanephric develop- 
ment was able to prevent this process suggests that rescue 
from apoptosis is a necessary condition for morphogenesis. 
Immediately  following induction,  the  mesenchymal  cells 
proliferate (21). Prevention of apoptosis is obviously neces- 
sary to allow proliferation, an early step in metanephric de- 
velopment. Our finding that the mesenchyme is programmed 
for apoptosis suggests that the inductive signal must perform 
at least two functions, apoptosis must be first prevented fol- 
lowing which, the mesenchyme has to convert to epithelia 
and differentiate. 
There  was  a  substantial  quantitative  difference in  the 
amount of DNA degradation between the in vivo results of 
Table I and the in vitro studies of Figs.  1-7. The extent of 
baseline degradation in vitro was much greater. During kid- 
ney development, the ureteric bud invades the mesenchyme 
and a complex process occurs, in which the mesenchyme is 
induced to differentiate and proliferate while the ureteric bud 
is induced to branch. Studies on the mechanism of induction 
have suggested that uretedc bud cells might have to contact 
the mesenchymal cells in order to induce them. Hence, the 
process of branching during invasion allows more and more 
ureteric bud cells to contact mesenchymal cells. During the 
in vitro experiments, the inducing material, the spinal cord, 
was  added  to the outside of the  mesenchymal rudiment. 
Hence, one likely reason for the small effect seen is that the 
access of the inducing cells to their target was limited to the 
peripheral cells. The majority of the mesenchymal cells, be- 
ing at the center of the solid mass of mesenchyme, will not 
6e induced and hence, undergo apoptosis. 
Apoptosis can be induced in some tumor cells, e.g., by 
treatment with tumor necrosis factor (13) or by the addition 
of glucocorticoids to mature B cells, (26). However, it has 
also been observed following withdrawal of a  stimulating 
factor such as interleukin-2 from mature T cells (3) or eryth- 
ropoietin from hemopoietic cells (12). In developing dorsal 
root ganglia withdrawal of nerve growth factor (NGF) l re- 
suits in programmed cell death (14).  These results suggest 
that apoptosis might be used in two classes of processes. In 
one, a stimulus is needed to activate cell suicide. In the other 
model, the suicide genes are continuously activated but are 
1. Abbreviation  used in this paper:  NGE nerve growth factor. 
suppressed by factors that are produced by other cells. The 
second class of mechanism received recent support from the 
identification of the ced-9 gene in C. elegans. Genetic anal- 
ysis demonstrated that a gain of function mutation of ced-9 
resulted in the survival of cells of a large number of lineages 
(8).  These studies demonstrate that apoptosis needs to be 
prevented in a variety of cells to assure survival. The rele- 
vance of these studies to metanephric development is high- 
lighted by our finding that induction must rescue the meta- 
nephric cells before tubulogenesis can occur. 
The factor that mediates this rescue needs to be deter- 
mined. Whether it is the same as that which causes induction 
awaits its isolation. The metanephric mesenchyme is already 
known to produce or respond to several growth factors. Re- 
cently, it was found that NGF receptors are present in de- 
veloping kidney mesenchyme and that antisense suppression 
of the NGF receptor resulted in interruption of the develop- 
mental program of the induced metanephric mesenchyme 
(23). Similarly, addition of antibodies to insulin like growth 
factor or transforming growth factor alpha prevented tubulo- 
genesis  (19, 20).  However, it is  not possible using  these 
studies to determine the precise stage at which these factors 
act. One mechanism by which soluble growth factors might 
affect renal development is by rescuing metanephric mesen- 
chyme from apoptosis. Our studies demonstrating that apop- 
tosis can be prevented by EGF or protein kinase C activators 
raises the possibility that a factor which activates a tyrosine 
kinase (e.g.,  EGF) or one that activates protein kinase C 
might rescue mesenchyme from apoptosis.  Recent studies 
have suggested that for NGF action to occur, the low affinity 
NGF receptor must bind to another receptor of the tyrosine 
kinase type to form a high affinity receptor (2).  That we 
found that  epidermal  growth  factor,  another activator of 
tyrosine phosphorylation, prevents DNA degradation sug- 
gests that activation of tyrosine kinases might be involved in 
the prevention of apoptosis. 
A chromosomal translocation at the bcl2 locus results in 
a lymphoma suggesting that prevention of apoptosis is im- 
portant for unrestricted growth (10). The bcl2 gene is a pro- 
tein located in the inner mitochondrial membrane but its 
function is  unknown.  Recent studies  in  germinal  follicle 
lymphocytes have suggested that inhibition of apoptosis (by 
activation of  the bcl2 oncogene) is not sufficient for prolifera- 
tive growth which  requires the  additional  activation of a 
c-myc type of oncogene (15, 25).  Hence, the inhibition of 
apoptosis in this model system appears to require at least two 
processes. Whether they are acting in parallel or in series, 
remains to be determined. That epidermal growth factor and 
phorbol esters can both prevent apoptosis but do not cause 
tubulogenesis suggests that the prevention of apoptosis in 
this system might also require the activation of at least two 
processes. Whether a single molecule is capable of  perform- 
ing both functions or two or more factors are required re- 
mains to be discovered. In addition, the same or additional 
factors will be needed to convert the rescued mesenchyme 
to epithelial cells and to initiate nephrogenesis. It is interest- 
ing in this regard that a variety of antibodies to growth fac- 
tors and extracellular matrix proteins have been found to in- 
hibit kidney development in vitro. Since kidney development 
occurs in many stages it would be important to develop as- 
says that would allow definition of the stages at which these 
inhibitory factors work. 
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the mesenchyme eventually  forms the mature epithelium. 
Since induction results in an early phase of proliferation (21), 
the fraction of mesenchyme that gets selected for differentia- 
tion is unknown but is likely to be small since DNA degrada- 
tion appears to be fast. It has been suggested that cell to cell 
contact might be responsible for induction (6, 21). If this turns 
out to be correct, it is likely that only a limited number of 
targets  (mesenchyme cells) would be accessible to the ure- 
teric bud cells. This might be the explanation of the small 
effect of the embryonic spinal cord on DNA degradation. 
However, it is also possible that the inducing material is pro- 
duced in limiting amounts. 
Metanephric apoptosis is fast and the natural inducer (the 
ureteric bud) originates from a distant source which has to 
travel to contact the mesenchyme; hence, metanephric de- 
velopment has to occur within a limited time period.  Be- 
cause of this,  it is perhaps  not surprising  that congenital 
absence of one kidney in humans is such a common occur- 
rence, appearing  in 1 in 1,000 live births. 
This work was supported by grants from National Institutes of Health 
DIC20999. 
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